KLRI Home
> Research
> Current
> Publications
Objective: Microvesicles (or microparticles) are a circulating, heterogeneous population of phospholipid-rich spheres formed from membranes of activated cells. Microvesicles carry molecular signatures of their cell of origin and provide surfaces for thrombin generation and thus, could indicate early disease processes. Experiments were designed to determine the relationship between the phenotype of circulating microvesicles to quantifiable vascular lesions in early menopausal women.
Methods: Microvesicles were prepared from blood collected into citrate-benzamidine anticoagulant from women being screened for the Kronos Early Estrogen Prevention Study (KEEPS) at Mayo Clinic, Rochester, MN and were evaluated by flow cytometry (FACS CantoTM) . Coronary arterial calcification (CAC) was evaluated by 64 slice CT scanner (Siemens).
Results: None of the women were hypertensive. Other usual risk factors for atherosclerotic disease were similar among women with low (Agatston scores 0<50; range 0.3-32), high (>50; range 93-315 Agatston units) CAC and negative calcium scores (Table). Only two women, in the low CAC group, were current smokers. However, the total number of microvesicles (Table), and the percentage of those of endothelial and platelet origin expressing surface phosphatidylserine were proportional to CAC. The thrombin generating capacity of microvesicles from the high CAC group (762±; 310 pM) was also significantly greater than that from individuals with negative calcium scores (260±; 16 pM).
Conclusion: Phenotypic characterization of blood borne microvesicles may provide value in identifying persons with cardiovascular disease who would not be identified by the usual risk factors.
Blood Borne Microvesicles and Coronary Calcification in Early Menopausal Women
Muthuvel Jayachandran, Robert D. Litwiller, Whyte G. Owen, John A. Heit, Thomas Behrenbeck, Sharon L. Mulvagh, Philip A. Araoz, MAYO CLINIC ROCHESTER, Rochester, MN; Matthew J. Budoff, Los Angeles Biomedical Res. Inst. at Harbor UCLA, Torrance, CA; S. Mitchell Harman, Kronos Longevity Inst., Phoenix, AZObjective: Microvesicles (or microparticles) are a circulating, heterogeneous population of phospholipid-rich spheres formed from membranes of activated cells. Microvesicles carry molecular signatures of their cell of origin and provide surfaces for thrombin generation and thus, could indicate early disease processes. Experiments were designed to determine the relationship between the phenotype of circulating microvesicles to quantifiable vascular lesions in early menopausal women.
Methods: Microvesicles were prepared from blood collected into citrate-benzamidine anticoagulant from women being screened for the Kronos Early Estrogen Prevention Study (KEEPS) at Mayo Clinic, Rochester, MN and were evaluated by flow cytometry (FACS CantoTM) . Coronary arterial calcification (CAC) was evaluated by 64 slice CT scanner (Siemens).
Results: None of the women were hypertensive. Other usual risk factors for atherosclerotic disease were similar among women with low (Agatston scores 0<50; range 0.3-32), high (>50; range 93-315 Agatston units) CAC and negative calcium scores (Table). Only two women, in the low CAC group, were current smokers. However, the total number of microvesicles (Table), and the percentage of those of endothelial and platelet origin expressing surface phosphatidylserine were proportional to CAC. The thrombin generating capacity of microvesicles from the high CAC group (762±; 310 pM) was also significantly greater than that from individuals with negative calcium scores (260±; 16 pM).
Conclusion: Phenotypic characterization of blood borne microvesicles may provide value in identifying persons with cardiovascular disease who would not be identified by the usual risk factors.
| Age (years) | Months past menopause | BMI (Kg/m2) | Total Cholesterol (mg/dL) | LDL (mg/dL) | HDL (mg/dL) | Total Number of micro- vesicles/ µL Plasma | |
| Negative CAC (n=10) | 53.1±0.3a | 21.4±2.9 | 26.1±1.2 | 208.5±11.3 | 125.8±30.1 | 62.8±3.6 | 584±94 |
| Low 0<50 CAC Score (n=18) | 53.1±0.4 | 16.8±2.1 | 27.9±1.0 | 213.2±9.5 | 133.8±6.9 | 57.3±4.4 | 810±153 |
| High >50 CAC Score (n=5) | 54.8±1.2 | 25.0±3.8 | 28.6±3.1 | 213.0±12.6 | 120.68±10.8 | 59.05±8.08 | 2376±1169* |
*Data are shown as mean±;SEM; *<0.05 from low and negative CAC
Phone: (866) 840-1117 - Fax: (602) 778-7490 - Email: info@kronosinstitute.org
Copyright 2010 KLRI. All rights reserved. Terms of Usage - Privacy Policy